Assessing The Sales Impact Of The New Health Insurance Exchange Market
Executive Summary
Many stakeholders have an interest in how the new health insurance exchanges mandated by the Affordable Care Act will impact product sales. While a multitude of known and unknown factors impact health insurance coverage decisions, and subsequently which services and products and services get used, surprisingly robust actuarial models used in the insurance industry are very applicable to forecasting product sales.
You may also be interested in...
Medicaid Expansion: Glass Half Full for Biopharma
Most health reform watchers have been tracking state votes on Medicaid expansion as a sort of scorecard on whether Obama Administration is winning or losing in health care reform. Push back from the states is making news now, but for biopharma sponsors, even a glass half full is a positive—and the long-term outlook is even brighter.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.